BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29483653)

  • 1. Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathy.
    Kotlarz D; Marquardt B; Barøy T; Lee WS; Konnikova L; Hollizeck S; Magg T; Lehle AS; Walz C; Borggraefe I; Hauck F; Bufler P; Conca R; Wall SM; Schumacher EM; Misceo D; Frengen E; Bentsen BS; Uhlig HH; Hopfner KP; Muise AM; Snapper SB; Strømme P; Klein C
    Nat Genet; 2018 Mar; 50(3):344-348. PubMed ID: 29483653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical parameters of inflammatory bowel disease in children do not correlate with four common polymorphisms of the transforming growth factor β1 gene.
    Liberek A; Jakóbkiewicz-Banecka J; Kloska A; Świderska J; Kmieć Z; Łuczak G; Wierzbicki P; Liberek T; Marek K; Plata-Nazar K; Sikorska-Wiśniewska G; Kamińska B; Węgrzyn G
    Acta Biochim Pol; 2011; 58(4):641-4. PubMed ID: 22140658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β1 protein and mRNA levels in inflammatory bowel diseases: towards solving the contradictions by longitudinal assessment of the protein and mRNA amounts.
    Liberek A; Kmieć Z; Wierzbicki PM; Jakóbkiewicz-Banecka J; Liberek T; Łuczak G; Plata-Nazar K; Słomińska-Frączek M; Kaszubowska L; Gabig-Cimińska M; Węgrzyn A
    Acta Biochim Pol; 2013; 60(4):683-8. PubMed ID: 24432317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bi-allelic LoF NRROS Variants Impairing Active TGF-β1 Delivery Cause a Severe Infantile-Onset Neurodegenerative Condition with Intracranial Calcification.
    Dong X; Tan NB; Howell KB; Barresi S; Freeman JL; Vecchio D; Piccione M; Radio FC; Calame D; Zong S; Eggers S; Scheffer IE; Tan TY; Van Bergen NJ; Tartaglia M; Christodoulou J; White SM
    Am J Hum Genet; 2020 Apr; 106(4):559-569. PubMed ID: 32197075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mRNA level of the transforming growth factor β1 gene, but not the amount of the gene product, can be considered as a potential prognostic parameter in inflammatory bowel diseases in children.
    Liberek A; Kmieć Z; Kartanowicz D; Wierzbicki PM; Stanisławowski M; Kaszubowska L; Luczak G; Góra-Gębka M; Landowski P; Szlagatys-Sidorkiewicz A; Liberek T; Kamińska B; Jakóbkiewicz-Banecka J; Węgrzyn G
    Int J Colorectal Dis; 2013 Feb; 28(2):165-72. PubMed ID: 22584294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.
    Krela-Kaźmierczak I; Michalak M; Wawrzyniak A; Szymczak A; Eder P; Łykowska-Szuber L; Kaczmarek-Ryś M; Drwęska-Matelska N; Skrzypczak-Zielińska M; Linke K; Słomski R
    Mol Biol Rep; 2017 Dec; 44(6):455-461. PubMed ID: 28993955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer.
    Troncone E; Marafini I; Stolfi C; Monteleone G
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer.
    Stolfi C; Troncone E; Marafini I; Monteleone G
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33375423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of transcription factor GATA-4 in inflammatory bowel disease and its possible regulation by TGF-beta1.
    Haveri H; Ashorn M; Iltanen S; Wilson DB; Andersson LC; Heikinheimo M
    J Clin Immunol; 2009 Jul; 29(4):444-53. PubMed ID: 19353247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Fraction from Lysate of a High Concentration Multi-Strain Probiotic Formulation Inhibits TGF-β1-Induced Intestinal Fibrosis on CCD-18Co Cells.
    Lombardi F; Augello FR; Palumbo P; Mollsi E; Giuliani M; Cimini AM; Cifone MG; Cinque B
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells.
    Schäfer H; Struck B; Feldmann EM; Bergmann F; Grage-Griebenow E; Geismann C; Ehlers S; Altevogt P; Sebens S
    Oncogene; 2013 Jan; 32(2):180-9. PubMed ID: 22349829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells.
    Cai Z; Zhang W; Li M; Yue Y; Yang F; Yu L; Cao X; Wang J
    Cell Mol Immunol; 2010 Jan; 7(1):35-43. PubMed ID: 20081874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine.
    Lawrance IC; Maxwell L; Doe W
    Inflamm Bowel Dis; 2001 Feb; 7(1):16-26. PubMed ID: 11233656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of latent transforming growth factor-β1, a conserved function for pregnancy-specific beta 1-glycoproteins.
    Warren J; Im M; Ballesteros A; Ha C; Moore T; Lambert F; Lucas S; Hinz B; Dveksler G
    Mol Hum Reprod; 2018 Dec; 24(12):602-612. PubMed ID: 30371828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbation of transforming growth factor (TGF)-beta1 association with latent TGF-beta binding protein yields inflammation and tumors.
    Yoshinaga K; Obata H; Jurukovski V; Mazzieri R; Chen Y; Zilberberg L; Huso D; Melamed J; Prijatelj P; Todorovic V; Dabovic B; Rifkin DB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18758-63. PubMed ID: 19022904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.
    Hahm KB; Im YH; Parks TW; Park SH; Markowitz S; Jung HY; Green J; Kim SJ
    Gut; 2001 Aug; 49(2):190-8. PubMed ID: 11454793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of TGF-β1 in homeostasis of the inflammation in sickle cell disease.
    Torres Lde S; Okumura JV; da Silva DG; Belini Júnior É; de Oliveira RG; Mimura KK; Lobo CL; Oliani SM; Bonini Domingos CR
    Cytokine; 2016 Apr; 80():18-25. PubMed ID: 26928604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of VEGF and TGF-β1 during exclusive enteral nutrition in IBD.
    Wedrychowicz A; Kowalska-Duplaga K; Jedynak-Wasowicz U; Pieczarkowski S; Sladek M; Tomasik P; Fyderek K
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):150-5. PubMed ID: 21788755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D prevents the intestinal fibrosis via induction of vitamin D receptor and inhibition of transforming growth factor-beta1/Smad3 pathway.
    Tao Q; Wang B; Zheng Y; Jiang X; Pan Z; Ren J
    Dig Dis Sci; 2015 Apr; 60(4):868-75. PubMed ID: 25326845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.